Back to Search
Start Over
Risk-adapted MRD-directed therapy for young adults with acute myeloid leukemia: 6-year update of the GIMEMA AML1310 trial
- Source :
- Blood Advances; August 2024, Vol. 8 Issue: 16 p4410-4413, 4p
- Publication Year :
- 2024
Details
- Language :
- English
- ISSN :
- 24739529 and 24739537
- Volume :
- 8
- Issue :
- 16
- Database :
- Supplemental Index
- Journal :
- Blood Advances
- Publication Type :
- Periodical
- Accession number :
- ejs66875452
- Full Text :
- https://doi.org/10.1182/bloodadvances.2024013182